This paper is only available as a PDF. To read, Please Download here.
Abstract
The topical agents developed thus far to treat male-pattern baldness have provided
encouraging results, but with continued efforts other new, more effective compounds
are certain to be developed in the future in this promising new area of dermatologic
research.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinics in DermatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Topical minoxidil therapy for hereditary male pattern alopecia.Cutis. 1987; 39: 337-342
- Hypotensive agents: diazoxide. 24. American Society of Hospital Pharmacists, ]Bethesda1987: 809-812
- Hypertrichosis due to diazoxide.Br J dermatol. 1975; 93: 707-711
- A double blind, placebo controlled study assessing the efficacy of CL 115–347 in promoting hair growth when administered for 24 weeks to the scalp of male subjects with male pattern baldness.CL 115–347, Clinical Study Protocol. 1985; (data of file): 1-28
- Cyclosporine and male pattern alopecia.Arch dermatol. 1987; 123: 1432
Article info
Identification
Copyright
© 1988 Published by Elsevier Inc.
